The cigarette firm posted $1.09 in earnings per share (EPS) and $5.06 billion in revenue for the second quarter, which compares with consensus estimates that called for $1.06 in EPS and revenue of $5.04 billion
-5- "Over the past two decades, Page 150 and 151: 0 Page 152 and 153: Page 154 and 155:
Sometimes a pipe can turn sour, typically if it lacks resting time between smokes
Like each sort of place where Johnson & Johnson became vulnerable from a liability and courtroom perspective, suddenly FDA was there to endorse Johnson & Johnson's decisions and statements
Authors' contributions GJ participated in the design of the study, was responsible for coordination of trial activities, and helped draft the manuscript
Children and teenagers, it showed, eat more of these products than the rest of the population